Gaby Knecht

513 total citations
19 papers, 224 citations indexed

About

Gaby Knecht is a scholar working on Infectious Diseases, Virology and Hepatology. According to data from OpenAlex, Gaby Knecht has authored 19 papers receiving a total of 224 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 9 papers in Virology and 8 papers in Hepatology. Recurrent topics in Gaby Knecht's work include HIV/AIDS drug development and treatment (11 papers), HIV Research and Treatment (9 papers) and Hepatitis C virus research (8 papers). Gaby Knecht is often cited by papers focused on HIV/AIDS drug development and treatment (11 papers), HIV Research and Treatment (9 papers) and Hepatitis C virus research (8 papers). Gaby Knecht collaborates with scholars based in Germany, United States and Switzerland. Gaby Knecht's co-authors include Amina Carlebach, Annette Haberl, Nils von Hentig, Ivanka Krznaric, Peter Gute, Hartmut Stocker, Thomas A. Lutz, Tim Kümmerle, Annemarie Berger and Christoph Boesecke and has published in prestigious journals such as International Journal of Molecular Sciences, Antimicrobial Agents and Chemotherapy and Journal of Hepatology.

In The Last Decade

Gaby Knecht

18 papers receiving 217 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gaby Knecht Germany 9 140 108 92 71 31 19 224
Kathrin van Bremen Germany 7 92 0.7× 145 1.3× 73 0.8× 76 1.1× 60 1.9× 17 244
E. Wilkins United Kingdom 5 111 0.8× 76 0.7× 59 0.6× 71 1.0× 54 1.7× 7 190
Thomas Huleux France 10 116 0.8× 101 0.9× 95 1.0× 50 0.7× 23 0.7× 18 193
José Antonio Mata‐Marín Mexico 9 121 0.9× 150 1.4× 101 1.1× 78 1.1× 61 2.0× 41 273
Andrea Bregenzer Switzerland 8 166 1.2× 305 2.8× 289 3.1× 43 0.6× 42 1.4× 16 384
Nadia Mahjoub France 9 164 1.2× 118 1.1× 77 0.8× 78 1.1× 7 0.2× 26 242
Jean‐Michel Livrozet France 9 129 0.9× 77 0.7× 46 0.5× 120 1.7× 30 1.0× 20 235
Kevin R. Frost United States 7 187 1.3× 117 1.1× 62 0.7× 117 1.6× 31 1.0× 9 276
Margherita Bracchi United Kingdom 7 187 1.3× 98 0.9× 29 0.3× 126 1.8× 75 2.4× 25 268
Daniela Francisci Italy 11 161 1.1× 82 0.8× 21 0.2× 121 1.7× 38 1.2× 33 250

Countries citing papers authored by Gaby Knecht

Since Specialization
Citations

This map shows the geographic impact of Gaby Knecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gaby Knecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gaby Knecht more than expected).

Fields of papers citing papers by Gaby Knecht

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gaby Knecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gaby Knecht. The network helps show where Gaby Knecht may publish in the future.

Co-authorship network of co-authors of Gaby Knecht

This figure shows the co-authorship network connecting the top 25 collaborators of Gaby Knecht. A scholar is included among the top collaborators of Gaby Knecht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gaby Knecht. Gaby Knecht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Graf, Christiana, Lara Fuhrmann, Thomas A. Lutz, et al.. (2023). Expanding epidemic of recently acquired HCV in HIV-coinfected patients over a period of 10 years. JHEP Reports. 5(7). 100701–100701. 2 indexed citations
2.
Graf, Christiana, Gaby Knecht, Christoph Stephan, et al.. (2020). Acute hepatitis C virus infection: a prospective ten-year observational study of HCV-mono and HCV/HIV-coinfected patients. Journal of Hepatology. 73. S319–S320. 1 indexed citations
3.
Spinner, Christoph D., et al.. (2018). 2016 PREP attitudes in Germany: high awareness and acceptance in MSM at risk of HIV. Infection. 46(3). 405–408. 19 indexed citations
4.
Spinner, Christoph D., Christoph Boesecke, Christoph Wyen, et al.. (2018). Prevalence of asymptomatic sexually transmitted infections in HIV-positive men who have sex with men in Germany: results of a multicentre cross-sectional study. Infection. 46(3). 341–347. 16 indexed citations
5.
6.
Grammatikos, Georgios, Julia Dietz, Nerea Ferreirós, et al.. (2016). Persistence of HCV in Acutely-Infected Patients Depletes C24-Ceramide and Upregulates Sphingosine and Sphinganine Serum Levels. International Journal of Molecular Sciences. 17(6). 922–922. 16 indexed citations
7.
Dietz, Julia, Thomas A. Lutz, Gaby Knecht, et al.. (2015). Evolution and function of the HCV NS3 protease in patients with acute hepatitis C and HIV coinfection. Virology. 485. 213–222. 3 indexed citations
8.
Wolf, Timo, Pavel Khaykin, Annemarie Berger, et al.. (2014). Improved virological and immunological efficacy of resistance-guided switch in antiretroviral therapy: a Frankfurt HIV cohort analysis. Medical Microbiology and Immunology. 203(6). 409–414. 4 indexed citations
9.
10.
Bhattacharya, Debika, et al.. (2013). Combination of allele-specific detection techniques to quantify minority resistance variants in hepatitis B infection: A novel approach. Journal of Virological Methods. 190(1-2). 34–40. 3 indexed citations
11.
Vermehren, Johannes, Amina Carlebach, Thomas A. Lutz, et al.. (2012). Assessment of liver fibrosis and associated risk factors in HIV-infected individuals using transient elastography and serum biomarkers. BMC Gastroenterology. 12(1). 27–27. 19 indexed citations
12.
Stephan, Christoph, Eva Herrmann, Nils von Hentig, et al.. (2012). Impact of HIV-1 replication on immunological evolution during long-term dual-boosted protease inhibitor therapy. Medical Microbiology and Immunology. 202(2). 117–124. 3 indexed citations
13.
Dietz, Julia, Gaby Knecht, Peter Gute, et al.. (2012). 1104 ANALYSIS OF VIRAL FACTORS, CLINICAL PARAMETERS AND IL28B ASSOCIATED WITH OUTCOME OF PATIENTS WITH ACUTE HEPATITIS C AND HIV COINFECTION. Journal of Hepatology. 56. S434–S435.
14.
Stürmer, Martin, Christoph Stephan, Peter Gute, et al.. (2011). Comparison of Drug Resistance Scores for Tipranavir in Protease Inhibitor-Naïve Patients Infected with HIV-1 B and Non-B Subtypes. Antimicrobial Agents and Chemotherapy. 55(11). 5362–5366. 4 indexed citations
15.
Vogel, Martin, Bernd Kupfer, Hans‐Jürgen Stellbrink, et al.. (2010). Phylogenetic analysis of acute hepatitis C virus genotype 4 infections among human immunodeficiency virus-positive men who have sex with men in Germany. Liver International. 30(8). 1169–1172. 29 indexed citations
16.
Stephan, Christoph, H. Jaeger, Gaby Knecht, et al.. (2010). Safety and efficacy after switch to a saquinavir-containing antiretroviral regimen in protease inhibitor pretreated HIV-positive patients. European journal of medical research. 15(9). 369–369. 1 indexed citations
17.
Hentig, Nils von, Gaby Knecht, Amina Carlebach, et al.. (2008). The steady-state pharmacokinetics of atazanavir/ritonavir in HIV-1-infected adult outpatients is not affected by gender-related co-factors. Journal of Antimicrobial Chemotherapy. 62(3). 579–582. 26 indexed citations
18.
19.
Hentig, Nils von, Amina Carlebach, Peter Gute, et al.. (2006). A comparison of the steady‐state pharmacokinetics of nevirapine in men, nonpregnant women and women in late pregnancy. British Journal of Clinical Pharmacology. 62(5). 552–559. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathrin van Bremen Breakdown of academic impact, for papers by E. Wilkins Breakdown of academic impact, for papers by Thomas Huleux Breakdown of academic impact, for papers by José Antonio Mata‐Marín Breakdown of academic impact, for papers by Andrea Bregenzer Breakdown of academic impact, for papers by Nadia Mahjoub Breakdown of academic impact, for papers by Jean‐Michel Livrozet Breakdown of academic impact, for papers by Kevin R. Frost Breakdown of academic impact, for papers by Margherita Bracchi Breakdown of academic impact, for papers by Daniela Francisci
Rankless by CCL
2026